Archive - Latest News Search Engine - Global and Local Breaking News

Frances Fisher says 'Rust' armorer was holding 'an armful of guns' the 1st time they met. 'I thought: It's very unsafe,' she says in new doc.

Frances Fisher says 'Rust' armorer was holding 'an armful of guns' the 1st time they met. 'I thought: It's very unsafe,' she says in new doc.

Bears again dominating the offseason, get plenty of help on offensive and defensive lines

Bears again dominating the offseason, get plenty of help on offensive and defensive lines

Trump Has Said ‘No Exceptions’ to His Tariffs. Will That Last?

Trump Has Said ‘No Exceptions’ to His Tariffs. Will That Last?

Kodiak Sciences Completes Enrollment in Second Registrational Trial of Tarcocimab in Patients with Diabetic Retinopathy

Kodiak Sciences Completes Enrollment in Second Registrational Trial of Tarcocimab in Patients with Diabetic Retinopathy

Your briefing

Frances Fisher says 'Rust' armorer was holding 'an armful of guns' the 1st time they met. 'I thought: It's very unsafe,' she says in new doc.

Frances Fisher says 'Rust' armorer was holding 'an armful of guns' the 1st time they met. 'I thought: It's very unsafe,' she says in new doc.

Bears again dominating the offseason, get plenty of help on offensive and defensive lines

The Bears worked hard to fix both lines.

Bears again dominating the offseason, get plenty of help on offensive and defensive lines

Trump Has Said ‘No Exceptions’ to His Tariffs. Will That Last?

His administration has acknowledged that exceptions undercut the power of tariffs, but it seems hard for the president to resist making deals.

Trump Has Said ‘No Exceptions’ to His Tariffs. Will That Last?

Kodiak Sciences Completes Enrollment in Second Registrational Trial of Tarcocimab in Patients with Diabetic Retinopathy

Topline clinical data of the confirmatory registrational study GLOW2 expected in 1Q 2026. GLOW2 study design mirrors GLOW1 study, which met primary en...

Kodiak Sciences Completes Enrollment in Second Registrational Trial of Tarcocimab in Patients with Diabetic Retinopathy